- Home
- GORV vs PYPD Comparison
GORV vs PYPD Comparison
Compare GORV & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- PYPD
- Stock Information
- Founded
- GORV 1976
- PYPD 2008
- Country
- GORV United States
- PYPD Israel
- Employees
- GORV N/A
- PYPD N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- PYPD Medical/Dental Instruments
- Sector
- GORV Consumer Discretionary
- PYPD Health Care
- Exchange
- GORV Nasdaq
- PYPD Nasdaq
- Market Cap
- GORV 22.6M
- PYPD 26.7M
- IPO Year
- GORV 2015
- PYPD 2020
- Fundamental
- Price
- GORV $0.16
- PYPD $2.90
- Analyst Decision
- GORV Hold
- PYPD Strong Buy
- Analyst Count
- GORV 2
- PYPD 2
- Target Price
- GORV $2.00
- PYPD $10.50
- AVG Volume (30 Days)
- GORV 261.8K
- PYPD 19.1K
- Earning Date
- GORV 05-15-2025
- PYPD 05-14-2025
- Dividend Yield
- GORV N/A
- PYPD N/A
- EPS Growth
- GORV N/A
- PYPD N/A
- EPS
- GORV N/A
- PYPD N/A
- Revenue
- GORV $871,562,000.00
- PYPD N/A
- Revenue This Year
- GORV $15.65
- PYPD N/A
- Revenue Next Year
- GORV $20.54
- PYPD N/A
- P/E Ratio
- GORV N/A
- PYPD N/A
- Revenue Growth
- GORV N/A
- PYPD N/A
- 52 Week Low
- GORV $0.20
- PYPD $2.30
- 52 Week High
- GORV $4.00
- PYPD $4.75
- Technical
- Relative Strength Index (RSI)
- GORV 30.45
- PYPD 56.83
- Support Level
- GORV $0.14
- PYPD $2.71
- Resistance Level
- GORV $0.22
- PYPD $2.89
- Average True Range (ATR)
- GORV 0.03
- PYPD 0.19
- MACD
- GORV 0.01
- PYPD 0.02
- Stochastic Oscillator
- GORV 13.64
- PYPD 56.25
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.